664 related articles for article (PubMed ID: 24560743)
1. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
[TBL] [Abstract][Full Text] [Related]
2. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
3. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.
Chang CW; Lai YS; Pawlik KM; Liu K; Sun CW; Li C; Schoeb TR; Townes TM
Stem Cells; 2009 May; 27(5):1042-9. PubMed ID: 19415770
[TBL] [Abstract][Full Text] [Related]
4. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette.
Somers A; Jean JC; Sommer CA; Omari A; Ford CC; Mills JA; Ying L; Sommer AG; Jean JM; Smith BW; Lafyatis R; Demierre MF; Weiss DJ; French DL; Gadue P; Murphy GJ; Mostoslavsky G; Kotton DN
Stem Cells; 2010 Oct; 28(10):1728-40. PubMed ID: 20715179
[TBL] [Abstract][Full Text] [Related]
5. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a reporter system to monitor silencing status in induced pluripotent stem cell lines.
Donai K; Kuroda K; Guo Y; So KH; Sone H; Kobayashi M; Nishimori K; Fukuda T
Anal Biochem; 2013 Dec; 443(1):104-12. PubMed ID: 23973628
[TBL] [Abstract][Full Text] [Related]
7. Generation of pig induced pluripotent stem cells with a drug-inducible system.
Wu Z; Chen J; Ren J; Bao L; Liao J; Cui C; Rao L; Li H; Gu Y; Dai H; Zhu H; Teng X; Cheng L; Xiao L
J Mol Cell Biol; 2009 Oct; 1(1):46-54. PubMed ID: 19502222
[TBL] [Abstract][Full Text] [Related]
8. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
[TBL] [Abstract][Full Text] [Related]
9. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
10. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
11. A robust strategy for negative selection of Cre-loxP recombination-based excision of transgenes in induced pluripotent stem cells.
Chakraborty S; Christoforou N; Fattahi A; Herzog RW; Leong KW
PLoS One; 2013; 8(5):e64342. PubMed ID: 23717601
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system.
Davis RP; Nemes C; Varga E; Freund C; Kosmidis G; Gkatzis K; de Jong D; Szuhai K; Dinnyés A; Mummery CL
Differentiation; 2013; 86(1-2):30-7. PubMed ID: 23933400
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
[TBL] [Abstract][Full Text] [Related]
14. Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species.
Imamura M; Okuno H; Tomioka I; Kawamura Y; Lin ZY; Nakajima R; Akamatsu W; Okano HJ; Matsuzaki Y; Sasaki E; Okano H
Methods Mol Biol; 2012; 925():21-48. PubMed ID: 22907488
[TBL] [Abstract][Full Text] [Related]
15. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
Liu J; Verma PJ
Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
[TBL] [Abstract][Full Text] [Related]
16. Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector.
Khan M; Narayanan K; Lu H; Choo Y; Du C; Wiradharma N; Yang YY; Wan AC
Biomaterials; 2013 Jul; 34(21):5336-43. PubMed ID: 23601660
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
18. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector.
Sommer CA; Sommer AG; Longmire TA; Christodoulou C; Thomas DD; Gostissa M; Alt FW; Murphy GJ; Kotton DN; Mostoslavsky G
Stem Cells; 2010 Jan; 28(1):64-74. PubMed ID: 19904830
[TBL] [Abstract][Full Text] [Related]
19. Gene targeting in human pluripotent stem cells.
Liu Y; Rao M
Methods Mol Biol; 2011; 767():355-67. PubMed ID: 21822888
[TBL] [Abstract][Full Text] [Related]
20. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.
Papapetrou EP; Sadelain M
Nat Protoc; 2011 Aug; 6(9):1251-73. PubMed ID: 21886095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]